334 related articles for article (PubMed ID: 26427870)
21. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
22. Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
Lee MA; Kim WK; Park HJ; Kang SS; Lee SK
Bioorg Med Chem Lett; 2013 Oct; 23(20):5511-4. PubMed ID: 24018191
[TBL] [Abstract][Full Text] [Related]
23. Aberrant activation of Wnt/β-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas.
Vidya Priyadarsini R; Senthil Murugan R; Nagini S
Oral Oncol; 2012 Jan; 48(1):33-9. PubMed ID: 21924667
[TBL] [Abstract][Full Text] [Related]
24. Glycoprotein nonmetastatic melanoma protein B accelerates tumorigenesis of cervical cancer in vitro by regulating the Wnt/β-catenin pathway.
Xu S; Fan Y; Li D; Liu Y; Chen X
Braz J Med Biol Res; 2018 Nov; 52(1):e7567. PubMed ID: 30484490
[TBL] [Abstract][Full Text] [Related]
25. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
[TBL] [Abstract][Full Text] [Related]
26. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
[TBL] [Abstract][Full Text] [Related]
27. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway.
Liu F; Tong D; Li H; Liu M; Li J; Wang Z; Cheng X
Oncotarget; 2016 Feb; 7(8):8896-907. PubMed ID: 26758421
[TBL] [Abstract][Full Text] [Related]
28. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells.
Ren K; Zhang W; Wu G; Ren J; Lu H; Li Z; Han X
Biomed Pharmacother; 2016 Dec; 84():1748-1759. PubMed ID: 27876206
[TBL] [Abstract][Full Text] [Related]
29. A small molecule compound 759 inhibits the wnt/beta-catenin signaling pathway via increasing the Axin protein stability.
Sun S; Gong YD; Kang JS; Dong MS; Choi Y
Med Oncol; 2024 May; 41(6):147. PubMed ID: 38733492
[TBL] [Abstract][Full Text] [Related]
30. Inhibiting MNK Selectively Targets Cervical Cancer via Suppressing eIF4E-Mediated β-Catenin Activation.
Zhang W; Su X; Li S; Wang Y; Wang Q; Zeng H
Am J Med Sci; 2019 Sep; 358(3):227-234. PubMed ID: 31327462
[TBL] [Abstract][Full Text] [Related]
31. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
Bi Y; Jiang Y; Li X; Hou G; Li K
J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.
Bi X; Xia X; Mou T; Jiang B; Fan D; Wang P; Liu Y; Hou Y; Zhao Y
Eur J Pharmacol; 2014 Nov; 742():145-52. PubMed ID: 25199964
[TBL] [Abstract][Full Text] [Related]
34. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
Yang F; Zeng Q; Yu G; Li S; Wang CY
Cell Signal; 2006 May; 18(5):679-87. PubMed ID: 16084063
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
36. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
37. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
Hsu W; Liu L; Chen X; Zhang Y; Zhu W
Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
[TBL] [Abstract][Full Text] [Related]
38. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin.
Lee EJ; Jo M; Rho SB; Park K; Yoo YN; Park J; Chae M; Zhang W; Lee JH
Int J Cancer; 2009 Jan; 124(2):287-97. PubMed ID: 19003969
[TBL] [Abstract][Full Text] [Related]
39. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells.
Srivastava NS; Srivastava RAK
Phytomedicine; 2019 Jan; 52():117-128. PubMed ID: 30599890
[TBL] [Abstract][Full Text] [Related]
40. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]